Pfizer Inc. (PFE) Q4 2022 Earnings Results

Pfizer Beats on EPS, Stock Up 1.4%

Pfizer's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock reacted positively, rising 1.4%, likely driven by investor confidence in the company's ongoing product demand and operational strategies. However, the lack of revenue data and guidance may leave some investors cautious about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.14	N/A	+10.68%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their current product pipeline and market position. They are focused on sustaining growth despite market challenges.

Management highlighted the continued demand for their products.

They noted ongoing investments in research and development.

There was an emphasis on maintaining strong operational efficiency.

Pfizer Beats on EPS, Stock Up 1.4%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Up 1.4%

Key numbers

Management commentary